IMPRINT is a network focusing on maternal and neonatal immunisation, funded by the UK’s Medical Research Council (MRC). Its members support challenge-led interdisciplinary research and aim to strengthen capacity for research and innovation within the UK and in low- and middle-income countries. IMPRINT is coordinated by Network Director Prof. Beate Kampmann (London School of Hygiene and Tropical Medicine) and Co-Director A/Prof. Chrissie Jones (University of Southampton).
IMPRINT brings together people working with PASSION
Since 2017, IMPRINT has built a sustainable network of stakeholders from basic science, immunology, vaccinology, social sciences, industry, public health and national and international policy makers, to tackle the challenges in the best use of vaccines in pregnancy and in newborns, and in the long term to improve maternal and newborn health. With over 380 members from 51 countries that all share the same passion for maternal immunisation, IMPRINT has quickly become a highly productive, multi-disciplinary and innovative network that continues to make an impact.
Why should we vaccinate pregnant women and how do these vaccines work? IMPRINT created several short animations to answer your questions around the main theme of our network.
To watch these videos and to learn more about IMPRINT, our mission and the people involved, follow the link below.
On 14 March 2024, a dedicated IMPRINT session was held as part of the 6th International Maternal and Neonatal Immunisation Symposium (INMIS) in San José, Costa Rica.
On the 6th and 7th of February, the IMPRINT Network organized a face-to-face meeting in Kingston upon Thames, UK.
The preliminary programme for IMPRINT's long-awaited in-person meeting in Kingston, UK, on the 6th and 7th of February 2023 is now available.
